“We found that LGG transiently enriches for functions to potentially promote anti-inflammatory pathways in the resident microbes,” the authors wrote in their report, published in mBio this week (April 14).
LGG is a popular dietary supplement, which the study participants ate twice a day for about a month. Analyzing stool samples before and after the trial, Claire Fraser of the University of Maryland School of Medicine and her colleagues showed that the microbial composition didn’t seem to change much.
Rather, the changes the researchers observed occurred at the level of particular transcripts. “We found evidence for differential expression of genes involved in adhesion and a large number of genes involved in bacterial motility during probiotic consumption that were predominantly associated with Roseburia and Eubacterium motile gut species. These commensal gut bacteria are notable as producers of the short-chain fatty acid butyrate, which is the preferred nutrient for human colonocytes, has anti-inflammatory properties, and decreases epithelial permeability,” Fraser and her colleagues wrote.
“This is a new idea, that some probiotics may work by affecting the overall ecosystem of the gut,” Fraser said in a press release. “Previously we tended to think that LGG and other probiotics worked directly on the host.”